These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3514993)

  • 21. [GH-secretion capacity in Turner syndrome and its relations to clinical characteristics and effect of GH treatment--a comparison with pituitary dwarfism. The Committee for hGH treatment in Turner syndrome].
    Tanaka T; Hibi I; Shizume K
    Nihon Naibunpi Gakkai Zasshi; 1991 May; 67(5):597-610. PubMed ID: 1868920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed spontaneous pubertal growth spurt in girls with the Ullrich-Turner syndrome.
    Pelz L; Sager G; Hinkel GK; Kirchner M; Krüger G; Verron G
    Am J Med Genet; 1991 Sep; 40(4):401-5. PubMed ID: 1746600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of hormone-induced and chondrodystrophic growth disorders].
    Góth E
    Orv Hetil; 1970 May; 111(18):1039-45. PubMed ID: 5454003
    [No Abstract]   [Full Text] [Related]  

  • 24. [Results of growth hormone treatment in girls with Turner syndrome].
    Rongen-Westerlaken C
    Tijdschr Kindergeneeskd; 1988 May; 56 Suppl 1():31-2. PubMed ID: 3413772
    [No Abstract]   [Full Text] [Related]  

  • 25. [The use of growth hormone in pediatrics in pituitary dwarfism].
    Verron G
    Z Gesamte Inn Med; 1968 Aug; 23(16):Suppl:252-4. PubMed ID: 5727624
    [No Abstract]   [Full Text] [Related]  

  • 26. Physical growth in Brachmann-de Lange syndrome.
    Kousseff BG; Thomson-Meares J; Newkirk P; Root AW
    Am J Med Genet; 1993 Nov; 47(7):1050-2. PubMed ID: 8291522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [State of the organ of vision in children and adolescents with growth disorders].
    Kizel'man ZD; Kurbanov TG
    Probl Endokrinol (Mosk); 1972; 18(4):27-30. PubMed ID: 4652128
    [No Abstract]   [Full Text] [Related]  

  • 28. Skull changes in pituitary dwarfism and the syndrome of familial dwarfism with high plasma immunoreactive growth hormone--a Roentgenologic study.
    Scharf A; Laron Z
    Horm Metab Res; 1972 Mar; 4(2):93-7. PubMed ID: 5028227
    [No Abstract]   [Full Text] [Related]  

  • 29. [Proceedings: Clinical evaluation of etiological factors in pituitary dwarfism].
    Suwa J; Maesaka H; Tanaka T
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):278. PubMed ID: 4476394
    [No Abstract]   [Full Text] [Related]  

  • 30. [Current status of the growth hormone therapy in dwarfism].
    Shizume K
    Nihon Naibunpi Gakkai Zasshi; 1984 Dec; 60(12):1492-502. PubMed ID: 6529990
    [No Abstract]   [Full Text] [Related]  

  • 31. [Our experience with the management of pituitary dwarfism].
    Hníková O; Kracmar P; Subrt I
    Cesk Pediatr; 1978 Oct; 33(10):591-3. PubMed ID: 729061
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of the potential gonadotropin reserve with specific stimulation with "releasing hormone"].
    Benedetti A; Englaro GC; Di Chiara F; Franzolini L; Basile A; Macor S
    Folia Endocrinol; 1974 Jun; 27(3):303-27. PubMed ID: 4597342
    [No Abstract]   [Full Text] [Related]  

  • 33. The advantages of combined stimulation by arginine and insulin in the study of the secretion of growth hormone.
    Ruitton A; Tell G; David M; Rocard E
    Rev Eur Etud Clin Biol; 1972 Nov; 17(9):846-54. PubMed ID: 4653986
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical significance of anti-hGH antibody analysis].
    Takano K
    Nihon Rinsho; 1990 Feb; 48 Suppl():861-3. PubMed ID: 2355625
    [No Abstract]   [Full Text] [Related]  

  • 35. [Growth disorders. Classification, diagnosis, therapy. 2. Endocrine dwarfism, dwarfism in metabolic diseases, hypoxemic dwarfism, intestinal dwarfism].
    Butenandt O
    Fortschr Med; 1979 Nov; 97(43):1966-7. PubMed ID: 511074
    [No Abstract]   [Full Text] [Related]  

  • 36. Disorders of somatic growth.
    Bonati B; Cacciari E; Canossi GC; Cheli E; Della Casa L; Giordano G; Marotti G; Marrama P; Morabito F; Nicoletti I
    Panminerva Med; 1982; 24(4):269-74. PubMed ID: 7170111
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of pituitary nanism with human growth hormone. Indications, methods and results, perspectives].
    Job JC
    Ann Pediatr (Paris); 1985 Feb; 32(2):85-92. PubMed ID: 3977234
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical studies on the etiology of idiopathic pituitary dwarfism].
    Suwa S; Maesaka K; Tanaka T; Komiya K
    Horumon To Rinsho; 1976; 24(5):423-8. PubMed ID: 1033791
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results of thyroid function tests before and during treatment with homologous somatotropin in patients with hypophyseal-hypothalamic growth disorders].
    Willgerodt H; Lässker G
    Cesk Pediatr; 1972 Oct; 27(10):476-7. PubMed ID: 5078506
    [No Abstract]   [Full Text] [Related]  

  • 40. [Isolated and sporadic growth hormone insufficiency].
    Job JC; Sizonenko PC; Lemoigne P; Canlorbe P; Rossier A
    Arch Fr Pediatr; 1970; 27(7):713-32. PubMed ID: 5473167
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.